TNF and metabolic dysfunction-associated steatotic liver disease: Similar to unsatisfactory explanation for pathophysiology of nonalcoholic fatty liver disease (NAFLD) encompassing steatosis plus necroinflammation, controversy remains regarding the efficacy of therapeutic strategy targeting oxidative stress and TNF-α [4, 5] in the treatment of NAFLD.